Page results
-
The UCLH Macmillan Support and Information Service Coffee Morning — a welcoming space for anyone affected by cancer or blood conditions to connect, share experiences, and find support.
-
The National Hospital for Neurology and Neurosurgery (NHNN), part of UCLH NHS Foundation Trust, has been reaccredited under the prestigious Royal College of Anaesthetists (RCoA) Anaesthesia Clinical Services Accreditation (ACSA) demonstrating the hospital anaesthetists’ commitment to patient safety and excellence of care.
-
This page has been written for patients who are having radioactive iodine (131I) ablation and/or radioiodine treatment for thyroid cancer.
-
New precision therapy for bile duct cancer extends patients’ lives
-
Having proton beam therapy: information for children aged 9-12 patient information
-
This page is for parents and carers whose child is having radiotherapy treatment to the pelvis.
-
This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a video or telephone appointment.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the spine (backbone).
-
Having proton beam therapy: information for teenagers aged 13-17 patient information.
-
This page is designed to help parents/carers understand the process and what to expect during their child’s admission to the Paediatric ward.
File results
-
FOI/2023/0018 - A&E attendances/ admissions by patients of no fixed abode
-
FOI/2023/0014 - Surgery protocols/ standard operating procedures for a feticide
-
FOI/2023/0013 - Average waiting times for colonoscopy investigations
-
FOI/2023/0010 - Bardet-biedle Syndrome patient treatment and diagnosis
-
FOI/2022/0757 - Oncology services - staff/ patients
-
FOI/2022/0764 - Patients treated for drinks spiked/ spiked by needle injection
-
FOI/2022/0763 - Treatment of dermatological conditions
-
FOI/2022/0761 - NHS estates maintenance/ repairs
-
FOI/2022/0768 - Patients treated for Haemophila A
-
FOI/2022/0754 - Respiratory devices